Motor system abnormalities in heterozygous relatives of a D90A homozygous CuZn-SOD ALS patient of Finnish extraction

Journal of the Neurological Sciences

Volumn 169, Issue 1-2, 1999, Pages 49-55

  Mezei, Michelle ^a   Andersen, Peter M ^b   Stewart, Heather ^c   Weber, Markus ^a,c   Eisen, Andrew ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Benign focal amyotrophy; D90A (Asp90Ala) CuZn SOD mutation; Familial amyotrophic lateral sclerosis; Motor neuron disease

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; FEMALE; FINLAND; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; MUSCLE ATROPHY; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

AGED; CANADA; FEMALE; FINLAND; GENETIC MARKERS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUTATION; PEDIGREE; SUPEROXIDE DISMUTASE;

EID: 0032692215     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00215-4     Document Type: Article

References (41)

1. Bobowick A.R., Brody J.A. Epidemiology of motor-neuron diseases. New Engl J Med. 288:1973;1047-1055.
2. Forsgren L., Almay B.G.L., Holmgren G., Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 68:1983;20-29.
3. Haverkamp L.J., Appel V., Appel S.H. Natural history of amyotrophic lateral sclerosis in a database population. Brain. 118:1995;707-719.
4. Mulder D.W., Kurland L.T., Offord K.P., Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 36:1986;511-517.
5. Cudkowicz M.E., McKenna-Vasek D., Sapp P.E., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 2:1997;210-221.
6. Andersen P.M., Nilsson P., Keränen M.-L., et al. Phenotypic heterogeneity in MND patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain. 10:1997;1723-1737.
7. Orrell R.W., Habgood J.J., Gardiner I., et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology. 48:1997;746-751.
8. Shaw C.E., Enayat Z.E., Chioza B.A., et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol. 43:1998;390-394.
9. Boukaftane Y., Khoris J., Moulard B., et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci. 25:1998;192-196.
10. Jones C.T., Swingler R.J., Simpson S.A., Brock D.J.H. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet. 32:1995;290-292.
11. Andersen P.M., Forsgren L., Binzer M., et al. Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain. 119:1996;1153-1172.
12. Andersen PM. Amyotrophic lateral sclerosis and CuZn-superoxide dismutase. A clinical, genetic and enzymatic study. Doctoral thesis, Umeå University, Umeå, 1997.
13. Andersen P.M., Nilsson P., Ala-Hurula V., et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet. 10:1995;61-66.
14. Robberecht W., Aguirre T., Bosch L.V.D., Tilkin P., Cassiman J.J., Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology. 47:1996;1336-1339.
15. Kaplan J.P., Brooks B.R., Mitsumoto H., et al. Atypical familial amyotrophic lateral sclerosis (abstract). Am J Hum Genet. 59:(Suppl 1534):1996;A265.
16. Jackson M., Al-Chalabi A., Enayat Z.E., Chioza B., Leigh P.N., Morrison K.E. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol. 42:1997;803-807.
17. Ikeda M., Abe K., Aoki M., et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the CuZn-superoxide dismutase gene. Neurology. 45:1995;2038-2042.
18. Keränen M.-L., Ala-Hurula V.-M., Saarinen A., Andersen P.M., Marklund S.L. Familiaalinen amyotrofinen lateraaliskleroosi Pohjois-Suomessa. Duodecim. 112:1996;2026-2030.
19. Takahashi H., Makifuchi T., Nakano R., et al. Familial amyotrophic lateral sclerosis with a mutation in the CuZn-SOD superoxide dismutase gene. Acta Neuropathol. 88:1994;185-188.
20. Shibata N., Hirano A., Kobayashi M., et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol. 55:1996;481-490.
21. Kato S., Shimoda M., Watanabe Y., Nakashima K., Takahashi K., Ohama E. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol. 55:(10):1996;1089-1101.
22. Ince P.G., Tomkins J., Slade J.Y., Thatcher N.M., Shaw P.J. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol. 10:1998;895-904.
23. Orrell R.W., King A.W., Hilton D.A., Campbell M.J., Lane R.J.M., Belleroche J.Sd. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry. 59:1995;266-270.
24. Hayward C., Minns R.A., Swingler R.J., Brock D.J.H. Homozygosity of Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J Med Genet. 2:1998;174.
25. Calder V.L., Domigan N.M., George P.M., Donalson I.M., Winterbourn C.C. Superoxide dismutase (Glu100Gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers. Neurosci Lett. 189:1995;143-146.
26. Abe K., Aoki M., Ikeda M., Watanabe M., Hirai S., Itoyama Y. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci. 136:1996;108-116.
27. Al-Chalabi A., Andersen P.M., Nilsson P., et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet. 8:1999;157-164.
28. Nakano T., Tsukuda N., Yanagisawa N., et al. Familial motor neuron disease with cases of amyotrophic lateral sclerosis and spinal muscular atrophy. Rinsho Shinkeigaku. 25:1985;1119-1125.
29. Shaw P.J., Ince P.G., Goodship J., et al. Adult-onset motor neuron disease and infantile Werdnig-Hoffmann disease (spinal muscular atrophy type I) in the same family. Neurology. 42:1992;1477-1480.
30. Appelbaum J.S., Roos R.P., Salazar-Grueso E.F., et al. Intrafamilial heterogeneity in heriditary motor neuron disease. Neurology. 42:1992;1488-1492.
31. Boylan K.B., Cornblath D.R. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance. Ann Neurol. 32:1992;404-407.
32. Camu W., Billiard M. Coexistence of ALS and Werdnig-Hoffmann disease within a family. Muscle Nerve. 5:1993;569-570.
33. Clermont O., Burlet P., Lefebvre S., Bürglen L., Munnich A., Melki J. SMN gene deletions in adult-onset spinal muscular atrophy. Lancet. 346:1995;1712-1713.
34. Brahe C., Servidei S., Zappata S., Ricci E., Tonali P., Neri G. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet. 346:1995;741-742.
35. Roy N., Mahadevan M.S., McLean M., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:1995;167-178.
36. Marklund S.L., Andersen P.M., Forsgren L., Nilsson P., Ohlsson P.-I., Wikander G., Öberg A. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem. 2:1997;675-681.
37. Andersen P.M., Nilsson P., Forsgren L., Marklund S.L. CuZn-superoxide dismutase, extracellular-superoxide dismutase and glutathione peroxidase in blood from individuals homozygous for the Asp90Ala CuZn-superoxide dismutase mutation. J Neurochem. 2:1998;715-720.
38. Morita M., Abe K., Takahashi M., et al. A novel mutation Asp90Val in the SOD1 gene associated with Japanese familial ALS. Eur J Neurol. 4:1998;389-392.
39. Brown R.H. SOD1 aggregates in ALS: cause, correlate or consequence? Nature. 12:1998;1362-1365.
40. Radunovic A., Leigh P.N. CuZn superoxide dismutase gene mutations in ALS. Correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry. 61:1996;565-572.
41. Al-Chalabi A., Andersen P.M., Chioza B., et al. Recessive amyotrophic lateral sclerosis with the D90A SOD1 mutation shares a common founder: evidence for a linked protective factor. Hum Mol Genet. 13:1998;2045-2050.